RF excision biopsy for breast lesions gets NICE thumbs down
This article was originally published in Clinica
The UK's National Institute for Health and Clinical Excellence (NICE) has decided against the routine use of image-guided radiofrequency (RF) excision biopsy of breast lesions. The technique, arguably the most exciting of the latest round of interventional procedures (IPP) guidance, was found to lack evidence on the safety and efficacy of the technology. In addition, "there are concerns about the possibility of false-negative biopsy results", said NICE. As a result, it may only be used under special arrangements.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.